From chronic diarrhea to diagnosis: unmasking rare giant gastrinoma
DOI:
https://doi.org/10.18203/2349-2902.isj20252939Keywords:
Chronic diarrhoea, Giant gastrinoma, Neuroendocrine tumor, Zollinger ellison syndromeAbstract
Gastrinomas are rare neuroendocrine tumors, most commonly arising in the pancreas or duodenum and typically present with peptic ulcer disease and gastric acid hypersecretion. Atypical symptoms such as chronic diarrhoea and abdominal pain, along with partial response to proton pump inhibitors, may delay diagnosis and timely treatment. We report the case of a 35 years old male who presented with a one-year history of persistent watery diarrhoea and intermittent abdominal pain. Clinical examination revealed an abdominal mass and imaging demonstrated a giant pancreatic head lesion and biochemical analysis showed markedly elevated serum gastrin levels. Histopathology confirmed the diagnosis of gastrinoma. The unusually large tumor size, combined with an atypical presentation as chronic diarrhoea, highlights the diagnostic challenges associated with gastrinomas. This case underscores the importance of considering neuroendocrine tumors, including Zollinger–Ellison Syndrome (ZES), in the differential diagnosis of unexplained chronic diarrhoea and abdominal pain. Timely recognition and management are crucial to improving outcomes. Giant gastrinomas (>12 cm) with multifocality in the context of ZES have not been reported in the literature, making this case a unique addition.
Metrics
References
Zhang WD, Liu DR, Wang P, Zhao JG, Wang ZF, Chen L. Clinical treatment of gastrinoma: A case report and review of the literature. Oncol Lett. 2016;11(5):3433–7. DOI: https://doi.org/10.3892/ol.2016.4397
Rossi RE, Elvevi A, Citterio D, Coppa J, Invernizzi P, Mazzaferro V, et al. Gastrinoma and Zollinger Ellison syndrome: A roadmap for the management between new and old therapies. World J Gastroenterol. 2021;27(35):5890–907. DOI: https://doi.org/10.3748/wjg.v27.i35.5890
Sahithi PV, Nandi VP, Kandagaddala Y, Mulagapaka V, Onteddu LP, Onteddu NK, et al. Gastrinoma: a case of chronic diarrhoea. Cureus. 2025;17(3):56. DOI: https://doi.org/10.7759/cureus.81253
Chatzipanagiotou O, Schizas D, Vailas M, Tsoli M, Sakarellos P, Sotiropoulou M, et al. All you need to know about gastrinoma today. Gastrinoma and Zollinger‐Ellison syndrome: A thorough update. J Neuroendocrinol. 2023;35(4):13267. DOI: https://doi.org/10.1111/jne.13267
Efared B, Tassiou ElhIM, Bako ABA, Boubacar I, Boureima HS, Nouhou H. Sporadic Zollinger-Ellison syndrome in a patient with isolated mesenteric gastrinoma. Int J Surg Case Rep. 2024;116:109474. DOI: https://doi.org/10.1016/j.ijscr.2024.109474
Helbing A, Menon G, Karanchi H. Gastrinoma. In: StatPearls. Treasure Island (FL): StatPearls Publishing. 2025.
Jensen RT, Cadiot G, Brandi ML, De Herder WW, Kaltsas G, Komminoth P, et al. ENETS consensus guidelines for the management of patients with digestive neuroendocrine neoplasms: functional pancreatic endocrine tumor syndromes. Neuroendocrinology. 2012;95(2):98–119. DOI: https://doi.org/10.1159/000335591
Yao JC, Shah MH, Ito T, Bohas CL, Wolin EM, Van Cutsem E, et al. Everolimus for Advanced Pancreatic Neuroendocrine Tumors. N Engl J Med. 2011;364(6):514–23. DOI: https://doi.org/10.1056/NEJMoa1009290
Vinik A, Bottomley A, Korytowsky B, Bang YJ, Raoul JL, Valle JW, et al. Patient-reported outcomes and quality of life with sunitinib versus placebo for pancreatic neuroendocrine tumors: results from an international phase iii trial. Target Oncol. 2016;11(6):815–24. DOI: https://doi.org/10.1007/s11523-016-0462-5
Norton JA, Foster DS, Ito T, Jensen RT. Gastrinomas. Endocrinol Metab Clin North Am. 2018;47(3):577–601. DOI: https://doi.org/10.1016/j.ecl.2018.04.009